GlassScriptPhysician profile
Alison K Cooper
NPI 1649351297
$2,134.01
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $613 · 2021: $562 · 2022: $378.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.39 | 2019-2022 | |
| Therapeuticsmd, INC. | $282.78 | 2019-2021 | |
| Myovant Sciences INC. | $136.72 | 2021-2022 | |
| Millicent US INC | $115.60 | 2020 | |
| Aspira Women'S Health INC | $112.85 | 2019-2022 | |
| Scynexis, INC. | $111.33 | 2022 | |
| Minerva Surgical, INC | $99.59 | 2019-2021 | |
| Lupin INC. | $89.83 | 2019-2021 | |
| Evofem Biosciences, INC. | $85.28 | 2020-2022 | |
| Pfizer INC. | $79.63 | 2019-2022 | |
| Amgen INC. | $48.44 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $47.97 | 2019-2020 | |
| Exeltis, USA INC. | $46.96 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.42 | 2020-2021 | |
| Agile Therapeutics, INC. | $43.80 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $42.59 | 2019-2021 | |
| Duchesnay USA Incorporated | $41.09 | 2019 | |
| Mayne Pharma Commercial LLC | $39.83 | 2021-2022 | |
| Boston Scientific Corporation | $34.76 | 2019-2021 | |
| Allergan, INC. | $32.27 | 2019 | |
| Gilead Sciences, INC. | $29.08 | 2022 | |
| Mylan Pharmaceuticals INC. | $25.60 | 2020 | |
| Becton, Dickinson and Company | $20.47 | 2022 | |
| Merck Sharp & Dohme LLC | $16.20 | 2019 | |
| Virtus Pharmaceuticals LLC | $14.82 | 2021 | |
| Avion Pharmaceuticals | $12.42 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.08 | 2022 | |
| Coopersurgical, INC. | $11.21 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.